NIH Unveils Precision Medicine 'Working Laboratory' Plan
This article was originally published in Scrip
After hearing from hundreds of the nation's top scientists, which gathered at four workshops over the past six months, and receiving input from two public requests for information, a working group on Sept. 17 delivered a blueprint to National Institutes of Health (NIH) Director Francis Collins mapping the way forward for building a one-million person research cohort – the foundation of President Barack Obama's precision medicine initiative (PMI).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.